Pathologic Treatment Effect and Survival...

Interview with Victoria A. Sanchez, AuD, PhD, and Yaël Bensoussan, MD, MSc, authors of Why Hearing Health Must Be Part of Voice Biomarker Research. Hosted by Paul C. Bryson, MD, MBA. Related Content: Why Hearing Health Must Be Part of Voice Biomarker Research 

Interview with Molly N. Huston, MD, and William A. Strober, MD, MSCI, authors of Biofeedback vs Respiratory Retraining for Inducible Laryngeal Obstruction: A Randomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content: Biofeedback vs Respiratory Retraining for I ... Show More

Interview with Kristine A. Smith, MD, author of Evaluation of Practice Patterns for 6-Sinus Balloon Sinus Dilation; Jay F. Piccirillo, MD, author of Balloon Sinus Dilation Use; and Donald C. Lanza, MD, MS, author of Balloon Sinus Dilation—To Inflate or Not to Inflate. Hosted by P ... Show More

Dr Kevin Kalinsky from the Winship Cancer Institute of Emory University in Atlanta, Georgia, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of breast cancer. CME information and select publications here. 

Management and Ongoing Monitoring of Thyroid Neoplasms Join us as we dive deep into the approach for thyroid nodules with our two fantastic guests, Dr. Kaniksha Desai (Stanford Medicine) and Dr. Ana Chindris (Mayo Clinic)! Learn how to stratify these nodules for cancer risk and w ... Show More

In the second episode of a two-part series on surgical oncology, host Rick Greene, MD, FACS, is once again joined by Drs. John Stewart and Prakash Pendalai to discuss the important features of head and neck malignancies, benign and malignant gynecologic conditions, and principles ... Show More

In this episode, we have the honor of speaking with Professor John Myburgh, a former South African physician and researcher who has dedicated his life to improving the field of critical care medicine. Professor Myburgh has made significant contributions to the field of fluid resu ... Show More

<p>Renal cell carcinoma has an estimated lifetime prevalence of 2.3% for men and 1.3% for women in the US. Affected patients in early stages can have >94% cancer-specific survival. Author William Y. Kim, MD, of the University of North Carolina joins JAMA Associate Editor David L. ... Show More

<p class="MsoNormal">Dr. Edmund Tsui is joined by Dr. Majda Hadziahmetovic to discuss her meta-analysis and systematic review investigating the effectiveness of systemic and local treatments in slowing autoimmune retinopathy progression. From the Ophthalmology Science article, "< ... Show More

Dr. John Fleetham is joined by Luigi Taranto Montemurro, MD, Andrew Wellman, MD, PhD, and Seva Polotsky, MD, PhD to discuss the impact the combination of Atomoxetine and Oxybutynin has on reducing the severity of obstructive sleep apnea. 

<p>Editor's Summary by Preeti Malani, MD, MS, and Chris Muth, MD, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from <a class="related-article" href= "https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.18822?utm_s ... Show More

In this week's episode, Blood editor Dr. Laura Michaelis interviews author Dr. Taylor Brooks on his latest paper published in volume 146 issue 18 of Blood Journal. The conversation discusses outcomes of bispecific antibodies (epcoritamab or glofitamab) in treating aggressive B-ce ... Show More